Zegfrovy - QuickHealthLife

QuickHealthLife

QuickHealthLife

Drugs

2 Min Read

Zegfrovy, Zegfrovy, Sunvozertinib, EGFR exon 20 insertion NSCLC, NSCLC treatment, Zegfrovy side effects,, Zegfrovy cost, Zegfrovy clinical trial, Tyrosine kinase inhibitor, Lung cancer breakthrough, Targeted therapy for NSCLC,

onAugust 11, 2025

Zegfrovy (Sunvozertinib): Uses, Benefits, Side Effects, Cost & How It Works

What Is Zegfrovy (Sunvozertinib)? Zegfrovy is an oral EGFR tyrosine kinase inhibitor (TKI) specifically designed for NSCLC with…